These results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of focusing on ACKR3 as a unique way to modulate the opioid system, which could open new therapeutic avenues for opioid-connected Condi